Vimarsana
Biggest News Aggregation in the World

Page 8 - Nasdaq Caba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Caba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Caba Today - Breaking & Trending Today

Cabaletta Bio (NASDAQ:CABA) Shares Down 5.9% - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Shares Down 5.9%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Rating)’s share price was down 5.9% during mid-day trading on Tuesday . The stock traded as low as $7.69 and last traded at $8.08. Approximately 438,358 shares traded hands during trading, a decline of 10% from the average daily volume of 486,434 shares. The stock had previously closed at […]

Cabaletta Bio's (CABA) "Buy" Rating Reaffirmed at HC Wainwright - Vimarsana News

Cabaletta Bio's (CABA) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Get Rating) in a research note released on Monday, Benzinga reports. HC Wainwright currently has a $15.00 price objective on the stock. Several other research analysts also recently issued reports on the stock. Chardan Capital restated a buy rating and set a […]

Cabaletta Bio (NASDAQ:CABA) Earns Buy Rating from HC Wainwright - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Earns Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Get Rating) in a research report sent to investors on Monday, Benzinga reports. HC Wainwright currently has a $15.00 target price on the stock. A number of other equities analysts also recently commented on the stock. Morgan Stanley raised shares of Cabaletta […]

Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from Chardan Capital - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from Chardan Capital

Chardan Capital reissued their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Get Rating) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $12.00 price target on the stock. Chardan Capital also issued estimates for Cabaletta Bio’s FY2024 earnings at ($1.52) EPS. Several other research analysts have also […]

Source: wkrb13.com
Insider Buying: Cabaletta Bio, Inc. (NASDAQ:CABA) CEO Buys 141,873 Shares of Stock - Vimarsana News

Insider Buying: Cabaletta Bio, Inc. (NASDAQ:CABA) CEO Buys 141,873 Shares of Stock

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Rating) CEO Steven Nichtberger purchased 141,873 shares of the firm’s stock in a transaction that occurred on Tuesday, October 18th. The shares were bought at an average price of $0.99 per share, with a total value of $140,454.27. Following the completion of the acquisition, the chief executive officer now […]